Supplementary Figure 1 from Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Aaron P. Rapoport(University of Maryland, Baltimore), Carl H. June(University of Pennsylvania), Brendan M. Weiss(Heidelberg University), Kathleen Ruehle(University of Maryland, Baltimore), Andrea Brennan(University of Pennsylvania), Nicole A. Aqui(University of Pennsylvania), Hong‐Bin Fang(University of Maryland, Baltimore), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Edward A. Stadtmauer(University of Pennsylvania), Bruce L. Levine(University of Pennsylvania), Michael Kalos(Pillar College), Dan T. Vogl(University of Pennsylvania), Todd Milliron(University of Maryland, Baltimore), Yin Xu(Second Affiliated Hospital of Nanjing Medical University), Saul Yanovich(Virginia Commonwealth University Medical Center), Ashraf Badros(University of Maryland, Baltimore), Görgün Akpek(Banner MD Anderson Cancer Center), Zhaohui Zheng(Xijing Hospital), Ling Cai, Dean L. Mann, Sunita Philip(University of Maryland, Baltimore), Naseem Kerr(Parker Institute for Cancer Immunotherapy), Patricia Tsao(University of Pennsylvania), Andres M. Salazar, Alan S. Cross(University of Maryland, Baltimore)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k